Call for nominations: L’Oréal-UNESCO for Women in Science Awards 2019

Scientists and scientific institutions around the world are invited to present and nominate the most qualified candidates for the 2019 L’Oréal-UNESCO for Women in Science Awards, until 13 July 2018. Their active participation will ensure that the best female researchers from each continent are recognized and rewarded for their scientific excellence.

For the first time, the 2019 Awards will designate five outstanding researchers in the Physical Sciences, Mathematics and Computer Science, each working in one of the following regions: Africa and the Arab States, Asia-Pacific, Europe, Latin America & North America.

The Awards will be presented in March 2019 in Paris to the five women selected by an international jury for their outstanding contribution to scientific advancement. Each of the Award Laureates will receive €100,000.

The candidate must

  • be recognized for her personal scientific excellence among the international scientific community
  • be actively involved in scientific research
  • be involved in any field of the Physical Sciences, Mathematics or Computer Science
  • not be directly or personally involved in the For Women in Science programme, as a jury member or otherwise, in any country.

In order to nominate a candidate, please follow the registration procedure on the For Women in Science platform accessible via www.forwomeninscience.com(link is external) . From the website, you will be able to upload all the necessary documents in order to submit the nomination. Please note that nomination files must be submitted by midnight on 13 July 2018 (France GMT/UTC + 2h). Only completed nominations received through the platform by this deadline will be considered.
You may nominate several candidates or re-nominate a candidate you presented in the past.

Check Also

2022 SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship

Cette bourse clinique soutient un diplôme en médecine ou un diplôme combiné MD / PhD et a un intérêt direct à faire avancer la recherche et la traduction d'approches immunothérapeutiques pour le traitement des patients atteints d'un cancer du poumon.